The global blood platelets market size accounted for USD 5.72 billion in 2023 and is expected to reach around USD 9.86 billion by 2033 with a CAGR of 5.59% from 2024 to 2033.
Key Points
- North America led the market with the biggest market share in 2023.
- Asia Pacific is projected to expand at the fastest rate during the forecast period of 2024-2033.
- By application type, the platelet function disorder segment had a significant share of the market in 2023.
- By application type, the hemophilia segment is observed to witness a notable rate of growth during the forecast period.
- By platelets, the whole blood derived platelets segment dominated the market in 2023.
- By end-user, the hospitals segment led the market with the largest share in 2023.
- By end-user, the ambulatory surgical centers segment is observed to witness a significant rate of growth during the forecast period.
The blood platelets market encompasses a range of products and services related to platelet transfusions, diagnostic tests, and therapeutic interventions aimed at managing disorders related to platelet function or count. Platelets, also known as thrombocytes, play a crucial role in hemostasis and wound healing. The market for blood platelets is driven by factors such as increasing incidences of bleeding disorders, rising demand for platelet transfusions in surgical procedures, and advancements in platelet-related diagnostics and therapies. Moreover, the growing geriatric population, which is more prone to platelet-related disorders, further fuels market growth. The market is characterized by the presence of established pharmaceutical companies, blood banks, diagnostic laboratories, and research institutions contributing to product development, innovation, and market expansion.
Get a Sample: https://www.precedenceresearch.com/sample/3932
Growth Factors:
Several factors contribute to the growth of the blood platelets market. One significant factor is the increasing prevalence of bleeding disorders such as hemophilia, thrombocytopenia, and von Willebrand disease. These conditions necessitate platelet transfusions or therapies to manage bleeding episodes effectively. Additionally, advancements in platelet-related diagnostics, including tests for platelet count, function, and aggregation, drive market growth by enabling early detection and personalized treatment strategies. Furthermore, the rising adoption of automated blood collection and processing systems in blood banks and healthcare facilities streamlines platelet procurement, storage, and distribution, thus bolstering market expansion. Moreover, initiatives to raise awareness about blood donation and platelet transfusion safety contribute to market growth by augmenting the availability of platelet units for clinical use.
Region Insights:
The blood platelets market exhibits regional variations in terms of market size, growth dynamics, and regulatory landscape. North America dominates the market, driven by factors such as a high prevalence of bleeding disorders, well-established healthcare infrastructure, and robust research and development activities. The presence of key market players and favorable reimbursement policies further bolster market growth in this region. Europe also holds a significant market share, attributed to increasing healthcare expenditure, rising awareness about platelet-related disorders, and technological advancements in platelet transfusion techniques. Moreover, the Asia-Pacific region is witnessing rapid market growth due to improving healthcare infrastructure, growing healthcare expenditure, and rising awareness about the importance of platelet transfusions in managing bleeding disorders.
Blood Platelets Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 5.59% |
| Global Market Size in 2023 | USD 5.72 Billion |
| Global Market Size by 2033 | USD 9.86 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Application, By Platelets, and By End-user |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Blood Platelets Market Dynamics
Drivers:
Several drivers propel the growth of the blood platelets market. Technological advancements in platelet isolation, storage, and transfusion techniques enhance the safety and efficacy of platelet products, driving market expansion. Additionally, the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and immune disorders, which often require platelet transfusions as part of treatment protocols, boosts market demand. Furthermore, initiatives by government bodies and healthcare organizations to promote blood donation, ensure blood safety, and enhance transfusion practices contribute to market growth by ensuring a stable supply of platelets for clinical use.
Restraints:
Despite the growth prospects, the blood platelets market faces certain restraints that hinder market expansion. One significant restraint is the risk of transfusion-transmitted infections associated with platelet transfusions, despite stringent screening protocols and safety measures. Concerns regarding the limited shelf life of platelet products and the need for continuous blood donations pose logistical challenges for maintaining an adequate supply of platelets. Moreover, the high cost associated with platelet transfusions and related therapies limits market accessibility, especially in developing regions with limited healthcare infrastructure and resources.
Opportunities:
The blood platelets market presents several opportunities for growth and innovation. Expanding indications for platelet transfusions beyond bleeding disorders, such as in the management of sepsis, organ transplantation, and traumatic injuries, could significantly broaden the market scope. Moreover, advancements in regenerative medicine and cell-based therapies offer potential avenues for developing novel platelet-based products with enhanced therapeutic efficacy. Furthermore, strategic collaborations between pharmaceutical companies, research institutions, and healthcare organizations facilitate product development, clinical trials, and market penetration, thereby creating new opportunities for market expansion.
Read Also: Biliary Stents Market Size to Attain USD 762.42 Million by 2033
Recent Developments
- In February 2024, GC Biopharma’s ‘Alyglo’, South Korea’s first FDA-approved blood plasma, announced its launch in the U.S. to take place in July. ‘Alyglo’ marks a significant milestone for GC Biopharma as it enters the U.S. market with its innovative blood plasma product.
- In December 2023, in a study titled ‘Space Anemia,’ researchers explore the effects of a rocket launched on the human body. The intense gravitational forces experienced during the roughly eight-minute journey into orbit may lead to a phenomenon where blood cells burst, posing potential health risks for astronauts.
Blood Platelets Market Companies
- Arthrex, Inc.
- AdiStem Ltd.
- Arteriocyte Medical Systems, Inc.
- Biomet, Inc.
- Cesca Therapeutics, Inc
- DePuy Synthes, Inc.
- EmCyte Corporation
- Dr. PRP America LLC
- Exactech, Inc.
- Harvest Technologies Corp
Segments Covered in the Report
By Application
- Platelet Function Disorder
- Hemophilia
- Thrombocytopenia
- Perioperative Indication
By Platelets
- Whole Blood Derived Platelets
- Apheresis Derived Platelets
By End-user
- Hospitals
- Ambulatory Surgical Centers
- Blood Banks
- Research Laboratories
- Specialty Clinics
- Orthopedic Clinics
- Dermatology Clinics
- Dental Clinics
- Cancer Treatment Centers
- Trauma Centers
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/
